![Chad Morin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chad Morin
Compliance Officer chez KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Profil
Chad Morin is currently the Chief Compliance Officer & Vice President at Kiniksa Pharmaceuticals Ltd.
He previously worked as the Head-Compliance at ARIAD Pharmaceuticals, Inc. and as the Chief Compliance Officer & Vice President at bluebird bio, Inc. Mr. Morin completed his undergraduate degree at F.W.
Olin Graduate School of Business.
Postes actifs de Chad Morin
Sociétés | Poste | Début |
---|---|---|
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Compliance Officer | 01/10/2020 |
Anciens postes connus de Chad Morin
Sociétés | Poste | Fin |
---|---|---|
ARIAD PHARMACEUTICALS, INC. | Compliance Officer | - |
BLUEBIRD BIO, INC. | Compliance Officer | - |
Formation de Chad Morin
F.W. Olin Graduate School of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Kiniksa Pharmaceuticals Ltd.
![]() Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |